Health
Hinge Health launches comprehensive Migraine Care Program
SAN FRANCISCO, April 29, 2026--Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people
About this update from Hinge Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":283,"url":"https://media.zenfs.com/en/business-wire.com/ccdb09c9216d9b5a927f4870428c78ec"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5Z0lgdo5O9hid6ZzYCwXsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2Ng--/https://media.zenfs.com/en/business-wire.com/ccdb09c9216d9b5a927f4870428c78ec","width":480,"height":283}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Cleared by the FDA for migraine, Hinge Health’s Enso® delivers on-demand pain relief","length":84,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Already 125+ clients covering more than two million people have adopted the Migraine Care Program","length":97,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":181,"olType":false},{"type":"text","content":"SAN FRANCISCO, April 29, 2026--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people living with migraine, MSK pain, or both.","length":557,"tagName":"p"},{"type":"text","content":"Migraine affects one in six Americans, with double the prevalence for women versus men¹. Approximately 75% of those who suffer from migraine pain also have MSK pain² and the personal and financial burden is significant. People with migraine drive more than $16,000 in annual medical and pharmaceutical spend – over twice as much as those without migraine³. Nationally, migraine costs U.S. businesses an estimated $78 billion each year⁴, and drives absenteeism and reduced productivity.","length":485,"tagName":"p"},{"type":"text","content":""Migraine is one of the most disabling and widespread neurologic conditions, yet existing treatment options are insufficient," said Dr. Jeffrey Krauss, MD, Chief Medical Officer of Hinge Health. "The FDA recently cleared our proprietary Enso device for the treatment of migrain...